Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancerIn: Therapeutic Advances in Medical Oncology Jg. 13 (2021)Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expressionIn: Cancer Medicine Jg. 9 (2020) Nr. 13, S. 4527 - 4539Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisIn: Oncogenesis Jg. 9 (2020) Nr. 11, S. 102Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaIn: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884Online Volltext: dx.doi.org/
-
Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536In: Oncology Research and Treatment Jg. 40 (2017) Nr. 7-8, S. 435 - 439Online Volltext: dx.doi.org/
-
Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 9, S. 1733 - 1744Online Volltext: dx.doi.org/
-
Inactivation of Capicua drives cancer metastasisIn: Nature Genetics Jg. 49 (2017) Nr. 1, S. 87 - 96Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyIn: OncoTarget Jg. 8 (2017) Nr. 28, S. 45898 - 45917Online Volltext: dx.doi.org/ (Open Access)
-
Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung AdenocarcinomaIn: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S1201 - S1201
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805Online Volltext: dx.doi.org/
-
Alternative tumor suppressor mechanisms in lung carcinomas - modulation of senescence by growth factor-induced signalingIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. 1033Online Volltext: dx.doi.org/
-
MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanomaIn: Pigment Cell and Melanoma Research Jg. 28 (2015) Nr. 6, S. 736 - 740Online Volltext: dx.doi.org/
-
Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapiesIn: Oral Oncology Jg. 51 (2015) Nr. 5, S. e39Online Volltext: dx.doi.org/
-
Plasma sequencing to detect a multitude of secondary KIT resistance mutations in metastatic gastrointestinal stromal tumors (GIST)In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 10518Online Volltext: dx.doi.org/ Online Volltext
-
A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung CancerIn: The Journal of Biological Chemistry (JBC) Jg. 289 (2014) Nr. 8, S. 5208 - 5216Online Volltext: dx.doi.org/
-
Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer PatientsIn: PLoS ONE Jg. 9 (2014) Nr. 1, e85350Online Volltext: dx.doi.org/ (Open Access)
-
Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunityIn: Cell Death and Disease Jg. 5 (2014) Nr. 12, 1568Online Volltext: dx.doi.org/ (Open Access)
-
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyIn: Cell Death and Disease Jg. 5 (2014) Nr. 2, e1091Online Volltext: dx.doi.org/ (Open Access)
-
DOG1 Regulates Growth and IGFBP5 in Gastrointestinal Stromal TumorsIn: Cancer Research Jg. 73 (2013) Nr. 12, S. 3661 - 3670Online Volltext: dx.doi.org/
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082Online Volltext: dx.doi.org/
-
Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockadeIn: Oncogene Jg. 32 (2013) Nr. 23, S. 2873 - 2881Online Volltext: dx.doi.org/
-
Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant CancersIn: ACS Chemical Biology Jg. 8 (2013) Nr. 9, S. 1869 - 1875Online Volltext: dx.doi.org/
-
Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 8, S. 1385 - 1394Online Volltext: dx.doi.org/
-
Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 4, S. 545 - 554Online Volltext: dx.doi.org/
-
Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapiesIn: Blood Cancer Journal Jg. 2 (2012) Nr. 3, S. e60Online Volltext: dx.doi.org/ (Open Access)
-
Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancerIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 253
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204
-
Zug um Zug : Tumorzellen in Schach halten – Moderne Konzepte zur Behandlung des LungenkarzinomsIn: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 90 - 97Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancerIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078
-
Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung CancerIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 12, S. 1976 - 1983Online Volltext: dx.doi.org/ (Open Access)
-
Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *In: Der Internist Jg. 52 (2011) Nr. 6, S. 726 - 726
-
Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RASIn: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. Suppl. 4, S. 440Online Volltext: dx.doi.org/
-
Individualisierte Therapie für Patienten mit fortgeschrittenen LungenkarzinomenIn: TumorDiagnostik & Therapie Jg. 31 (2010) Nr. 2, S. 79 - 87Online Volltext: dx.doi.org/
-
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-γ1-driven activation of mTOR/p70S6-kinase pathwayIn: Oncogene Jg. 29 (2010) Nr. 5, S. 739 - 751Online Volltext: dx.doi.org/ (Open Access)
-
Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptorIn: Blood Jg. 113 (2009) Nr. 17, S. 4074 - 4077Online Volltext: dx.doi.org/
-
MA17.07 Identification of AHR as a Novel Regulator of Lung Cancer MetastasisIn: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S319Online Volltext: dx.doi.org/ (Open Access)
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227Online Volltext: dx.doi.org/ -
Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 76Online Volltext: dx.doi.org/ -
Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 116 - 117Online Volltext: dx.doi.org/ -
Functional characterization of DOG1 in Gastrointestinal Stromal Tumors (GIST)In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 1824Online Volltext: dx.doi.org/
-
Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) : a single center experience
37th ESMO Congress, 28 September - 2 October 2012, Vienna, Austria,In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438Online Volltext: dx.doi.org/ -
Inhibitors of apoptosis (IAPs) in gastrointestinal stromal tumorsIn: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 3855 - 3855Online Volltext: dx.doi.org/
-
Influence of Everolimus and Pemetrexed on Thymidylate Synthase expression as well as on Proliferation and survival of non-small cell ling Cancer CellsIn: Journal of Thoracic Oncology Jg. 5 (2010) Nr. Suppl. 1, S. S56 - S57Online Volltext: dx.doi.org/
-
Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
14th World Conference on Lung Cancer, July 3 – 7, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S956 - S957Online Volltext: dx.doi.org/